Abstract

Purpose Signal transducer and activator of transcription factor 3 (STAT3) is involved in tumorigenesis, development, and radioresistance of many solid tumors. The aim of this study is to investigate the effects of stattic (an inhibitor of STAT3) on the radiosensitivity and radio-induced migration and invasion ability in hepatocellular carcinoma (HCC) cell lines. Methods HCC cells were treated with stattic, and cell survival rate was analyzed through CCK-8 assay. Radiosensitivity was evaluated using cloning formation analysis; STAT3, p-STAT3, and apoptosis related proteins were detected by western blot. Radio-induced migration and invasion ability in HCC cells were analyzed by wound-healing assay and transwell test. Results Stattic inhibits the expression of p-STAT3 and reduces cell survival in a dose-dependent manner in HCC cell lines, and the IC50 values for Hep G2, Bel-7402, and SMMC-7721 are 2.94 μM, 2.5 μM, and 5.1 μM, respectively. Cloning formation analysis shows that stattic enhances the radiosensitivity of HCC cells. Wound-healing assay and transwell test show that stattic inhibits radio-induced migration and invasion. Further study indicates that stattic promotes radio-induce apoptosis through regulating the expression of apoptosis related proteins in HCC cells. Conclusion Stattic enhances radiosensitivity and reduces radio-induced migration and invasion ability in HCC cells probably through apoptosis pathway.

Highlights

  • Hepatocellular carcinoma (HCC) is a popular carcinoma and is the second leading cause of cancer-related death currently [1]

  • According to the IC50 of HCC cells and the preliminary experimental results of STAT3 phosphorylation assay, we determined the concentrations of stattic in the subsequent studies for different cell lines, and the dose of X-ray in different experiment was determined according to the results of pretest, such as 2 Gy in STAT3

  • We found that radiation enhanced the expression of p-STAT3, so we hypothesized that radiation promoted migration and invasion of HCC cells through enhancing activation of STAT3

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is a popular carcinoma and is the second leading cause of cancer-related death currently [1]. Surgery is the most effective therapy for HCC, but only approximately 10–30% of cases are operable, and the tumor always recurs and metastasizes to other organs after surgery. Radiotherapy is an effective treatment for locally advanced HCC, but its clinical application is limited because of the poor radiation tolerance of the liver and its surrounding tissues [5, 6]. As new radiotherapy technology has been used, such as intensity modulated radiotherapy (IMRT), image guided radiotherapy (IGRT), and three-dimensional conformal radiotherapy (3D-CRT), radiation-induced liver injuries have moderately decreased, but the technical improvement is limited.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call